The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
This new facility strengthens Latin America as a collaborative hub
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Biocytogen will provide proprietary, fully human antibodies derived from its RenMice platform for evaluation in Merck’s antibody-conjugated LNP services
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Subscribe To Our Newsletter & Stay Updated
